RDY241220C00105000 Option on Dr Reddys Laboratories

RDY Stock  USD 14.32  0.15  1.04%   

Dr Reddys Market Cap Over Time

   Market Cap   
       Timeline  

RDY Total Stockholder Equity

Total Stockholder Equity

294.58 Billion

At this time, Dr Reddys' Total Stockholder Equity is fairly stable compared to the past year.

Dr Reddys Corporate Directors

Leo PuriNon-Executive Independent DirectorProfile
Arunabha RayChaudhuriHead DirectorProfile
Prasad MenonLead Non-Executive Independent DirectorProfile
Shikha SharmaNon-Executive Independent DirectorProfile

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.